-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Named to the Top 100 Chinese Pharmaceutical Companies Ranking
Category:
发布时间：2024-04-07
【概要描述】
From March 27 to 31, the 2024 International Greater Health Industry Expo (Chongqing) and the 9th Dual-Product Fair were grandly held at the Chongqing Nanping International Convention and Exhibition Center.
From March 27 to 31, the 2024 International Greater Health Industry Expo (Chongqing) and the 9th Dual-Product Fair were grandly held at the Chongqing Nanping International Convention and Exhibition Center.
To encourage and guide the development and growth of pharmaceutical enterprises, and to enhance industry concentration and market competitiveness, the 2024 China Pharmaceutical Marketing Big Data Summit—a sub-forum of this conference—saw the official launch of the “2023 China Pharmaceutical Market Enterprise Rankings,” jointly released for the first time by Yaozhi Network and the Organizing Committee of the Greater Health Industry (Chongqing) Expo/Double Products Fair. Shijiazhuang Sihua Pharmaceutical Group was honored with inclusion in both the “Top 100 Chinese Pharmaceutical Market Enterprises 2023” and the “Top 100 Chemical Pharmaceutical Enterprises in the 2023 China Pharmaceutical Market.”
According to available information, the data for this ranking are sourced from the Yaozhi Pharmaceutical Sales Database, providing an objective reflection of pharmaceutical companies’ marketing strength and brand influence in the end-market in 2023.
In recent years, Shijiazhuang Sihua Pharmaceutical Group has focused on its core business and primary responsibilities, with innovation-driven development as its guiding principle. The company has vigorously implemented a “API-plus-formulation” development strategy, resulting in substantial progress in scientific research and innovation. Both the number of new product applications and the number of approvals have increased, demonstrating outstanding R&D quality and efficiency. As a result, the company ranks among the leaders in China’s pharmaceutical industry, effectively driving continuous optimization of its product portfolio and accelerating its journey toward high-quality development.
A spokesperson for the group stated that it will take it as its mission to “research, develop, and produce more ‘Chinese medicines’ tailored to the genetic heritage and physical characteristics of the Chinese population,” uphold technological self-reliance and strength, continuously optimize and expand its product pipeline, actively integrate into the new development paradigm, foster and develop new-quality productive forces, steadily accelerate the R&D and industrialization of its products, and strive to inject additional new engines and momentum into the high-quality development of both the company and Shijiazhuang’s biopharmaceutical industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091